Open Access Journal of Clinical Trials is a premier peer-reviewed journal published by DOVE MEDICAL PRESS LTD, dedicated to advancing the field of clinical pharmacology and medical research. With an impactful open access model initiated in 2009, this journal makes valuable research widely accessible, fulfilling the urgent need for rapid dissemination of scientific knowledge. The journal has established itself as a significant resource in its field, boasting impressive metrics with a 2023 Q2 ranking in Pharmacology (Medical) and a Q1 ranking in the Miscellaneous subsector of Pharmacology, Toxicology, and Pharmaceutics, underscoring its reputation for excellence. Based in New Zealand, the journal fosters global collaboration, and its comprehensive coverage spans various domains within pharmacology and clinical trials. Researchers and practitioners are encouraged to contribute to this vital discourse, as the journal serves as a platform for innovation, collaboration, and the exchange of groundbreaking findings in clinical trials.

BMJ Evidence-Based Medicine is a premier journal published by BMJ Publishing Group that focuses on the critical appraisal and application of scientific evidence in clinical practice. With its ISSN 2515-446X and E-ISSN 2515-4478, this impactful journal operates out of the United Kingdom and has established itself as a leading resource in the field of evidence-based medicine, reflected by its impressive Q1 ranking in the Medicine (miscellaneous) category and a significant 93rd percentile ranking amongst General Medicine titles on Scopus. Offering an essential platform for researchers, practitioners, and students alike, the journal disseminates high-quality research and reviews that significantly influence healthcare practices worldwide. The journal currently has access options available for readers through institutional subscriptions and individual licenses, making cutting-edge research easily accessible to those dedicated to advancing medical knowledge. With its commitment to evidence-based practice, BMJ Evidence-Based Medicine plays a crucial role in improving patient outcomes and informing clinical decisions.

Behavior Research Methods is a premier, peer-reviewed journal published by Springer that holds a significant position within the fields of psychology and behavioral science. With its ISSN 1554-351X and E-ISSN 1554-3528, this esteemed journal has been a vital resource for researchers and practitioners since its inception in 1968. By providing insightful research on innovative methodologies in behavioral studies, it has achieved remarkable recognition, consistently ranking in the Q1 category across various psychological disciplines including Developmental and Educational Psychology, Experimental and Cognitive Psychology, and Arts and Humanities. Its current Scopus rankings place it firmly within the top echelons of academic journals, with impressive percentiles in several categories. The journal's objective is to advance knowledge and foster discourse on effective research methods related to human behavior, making it an essential platform for sharing groundbreaking findings and innovative approaches. While it does not offer open access, it continues to serve as a key reference for those looking to enhance their understanding of methodological advancements in behavior research. The journal is available to scholars and institutions both in the United States and globally, affirming its role as a beacon of scholarly excellence in psychology.

BIOMETRICS, published by WILEY, stands as a prestigious journal that has made substantial contributions across diverse fields, including Agricultural and Biological Sciences, Applied Mathematics, and Biochemistry. With an impressive track record from its inception in 1946 and continuing through to 2024, this journal is recognized for its rigorous peer-reviewed research and high-impact findings, evidenced by its Q1 ranking in various categories such as Medicine and Statistics. Researchers and professionals alike will find a wealth of knowledge within its pages, making it an essential resource for anyone involved in these dynamic and evolving disciplines. While BIOMETRICS does not offer open access, its reputation for delivering high-quality research ensures its continued importance in advancing the scientific ecosystem. For those seeking to stay ahead in their fields, engaging with the latest studies published in this journal is indispensable.

BMC Medical Research Methodology is a prestigious open-access journal published by BMC, dedicated to advancing the field of medical research methodologies. Launched in 2001, the journal has established itself as a vital resource for researchers, reflecting its high-quality contributions with a strong Q1 ranking in both Epidemiology and Health Informatics as of 2023. As a scholarly platform, it offers broad access globally, ensuring that the latest developments in research methodology are readily available to professionals, scholars, and students alike. With its commitment to enhancing the rigor and transparency of medical research, BMC Medical Research Methodology plays a critical role in shaping the future of evidence-based practices, making it an essential read for anyone involved in medical research. The journal is based in the United Kingdom at CAMPUS, 4 Crinan St, London N1 9XW, England, and provides comprehensive access options to facilitate the dissemination of knowledge and foster collaboration across the global research community.

Welcome to the Journal of Evaluation in Clinical Practice, a respected publication in the fields of Health Policy and Public Health, released by Wiley. With over two decades of dedicated scholarship since its inception in 1995, this journal aims to advance the standards of clinical practice through rigorous evaluation and research. Ranked in the Q2 quartile, our journal stands out in its commitment to improving healthcare systems, evidenced by its high Scopus rankings (Rank #60 in Health Policy and Rank #163 in Public Health). Although it is not an open-access platform, we provide unparalleled insights into clinical evaluation methodologies, policy impacts, and health outcomes, making it an essential resource for researchers, practitioners, and students alike. Join us as we explore significant advancements and critical discussions at the intersection of clinical evaluation and public health, shaping the future of healthcare quality and effectiveness.

Ethik in der Medizin, published by Springer, is a distinguished journal focusing on the interdisciplinary aspects of ethics in medicine, healthcare policy, and philosophical inquiries related to these domains. With an ISSN of 0935-7335 and an E-ISSN of 1437-1618, this journal serves as a platform for innovative research and discussion from Germany and beyond. The journal boasts an impact in several prestigious categories including Q3 in Health Policy and Q2 in Philosophy as of 2023, reflecting its significant contribution to the discourse on ethical implications in health and medicine. Although not currently Open Access, Ethik in der Medizin provides valuable insights for researchers, professionals, and students interested in the complexities of health ethics and policies, positioning itself as an essential resource in academia. The journal is undergoing important developments, as it converges from 2001 with a publishing timeline extending to 2024, ensuring continued relevance in a rapidly evolving field.

Journal of EMDR Practice and Research, published by Springer Publishing Co, is an essential resource for professionals in the field of psychology and mental health, focusing specifically on Eye Movement Desensitization and Reprocessing (EMDR) therapy. Established in 2010, the journal spans a significant academic horizon, aiming to disseminate high-quality research and practical applications of EMDR in clinical settings. With an increasing scope that intersects with Biological Psychiatry, Cognitive Neuroscience, and Neuropsychology, the journal occupies an important niche evidenced by its latest Scopus rankings, including a Q3 classification in Experimental and Cognitive Psychology. Researchers and clinicians benefit from access to emerging findings that can inform their practices, ultimately improving the treatment outcomes for individuals facing trauma and related disorders. Although specific open access options may not be available, the journal remains committed to upholding high standards of scholarly contribution in the realm of mental health.

Clinical Trials, published by SAGE Publications Ltd, is a prestigious journal that serves as a vital resource for researchers, professionals, and students in the fields of medicine and pharmacology. Operating since 2004 and converging through 2024, this journal boasts an impressive standing in the academic community, achieving a Q1 categorization in both Medicine (miscellaneous) and Pharmacology as of 2023. The journal's Scopus rankings reflect its influential contributions, with a rank of #128 out of 636 in General Medicine and a 79th percentile placement, alongside a rank of #172 out of 313 in Pharmacology, indicating its significant role in advancing clinical research. Based in the United Kingdom, Clinical Trials focuses on disseminating high-quality studies that enhance the understanding of clinical processes and therapeutic methodologies. Although it does not currently offer Open Access, the journal provides a platform for traditional publication, ensuring the dissemination of critical knowledge in the healthcare domain.

Contemporary Clinical Trials Communications, published by ELSEVIER INC, serves as a pivotal resource in the evolving fields of medicine and pharmacology, especially with its commitment to open access since 2015. With the E-ISSN 2451-8654, this journal is dedicated to disseminating high-quality research that examines contemporary clinical trial methodologies and their applications in improving healthcare outcomes. Situated in the United States, its impressive ranking, with a Q2 status in both Medicine (miscellaneous) and Pharmacology for 2023, highlights its significance and impact within the scientific community. Ranking #199 out of 636 in General Medicine and #217 out of 313 in Pharmacology on the Scopus scale, the journal aims to foster innovative discussions and developments among researchers, professionals, and students, making it an essential tool for those seeking to stay at the forefront of clinical research and trials.